4//SEC Filing
Fairman Jeff 4
Accession 0001209191-22-027848
CIK 0001649094other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 4:35 PM ET
Size
6.5 KB
Accession
0001209191-22-027848
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Fairman Jeff
VP, Research
Transactions
- Sale
Common Stock
2022-05-05$25.80/sh−888$22,914→ 325,339 total(indirect: By Trust)
Holdings
- 16,629
Common Stock
- 50,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted-average price. The shares were sold at prices ranging from $25.58 to $26.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Vaxcyte, Inc.
CIK 0001649094
Entity typeother
Related Parties
1- filerCIK 0001813800
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 4:35 PM ET
- Size
- 6.5 KB